Success Stories: We Helped a Research Fellow from Iran in the Field of Biotechnologies Achieve NIW Approval With Our Efforts and Guidance
Client’s Testimonial:
“Thank you so much! It was an absolute pleasure to work with you. Your work was definitely 5 stars if not more and I already sent a few friends your way. I myself came to you by a friend’s recommendations and already knew how helpful you are in this whole very stressful process. Thank you again for all the work you put into my case:)”
On March 14th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biotechnologies (Approval Notice).
General Field: Biotechnologies
Position at the Time of Case Filing: Research Fellow
Country of Origin: Iran
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: March 14th, 2023
Processing Time: 5 months, 2 days
Case Summary:
With a Ph.D. in biomedical engineering and fundamental research experience, undoubtedly, our client possesses the ability to advance in the field of biotechnologies. When she contacted our law firm to file an I-140 NIW (National Interest Waiver) petition on her behalf, we examined more into her degrees and diplomas, and after thoroughly evaluating her credentials, we established that we would lead her to NIW success and countersigned the retainer agreement.
We intended to prove that she is an essential researcher in her field of expertise, therefore we added essential attributes to her NIW (National Interest Waiver) petition packet. We noted that her work:
- Cited 39 times by dependent and independent researchers, demonstrating that her publications are widely recognized and relied upon in her chosen field.
- Her contributions to peer-reviewed conference articles resulted in 3 peer-reviewed journal articles (1 of them first-authored).
- She has completed at least 4 reviews to date.
- Her work has been supported by funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF). This funding is reserved solely for research directed at advancing the national interest, including improving human health through the application of science and technology, as well as enhancing the national economy.
Additionally, she intends to continue her research on the development of protective and therapeutic interventions to mitigate chemotherapy-induced cardiotoxicity. Specifically, she will design a rodent model of psychosocial stress as a comorbid condition for cardiovascular disease, develop an exercise protocol to help mitigate the adverse effects of chemotherapy on the cardiovascular system, and publish original biotechnologies research in peer-reviewed journals and conference presentations.
To bolster our client’s case further, we added recommendation letters signed by four other expert scholars in the field. One of the excerpts is mentioned below:
“[Client] is an expert researcher in biomedical engineering whose work involves examining the properties of blood vessels in syndromes such as MFS and devising alternate diagnoses and treatment methods to achieve the best outcomes. Her work is vital to the U.S., as her research informs professionals of alternate means of addressing cardiovascular conditions such as MFS, which is necessary for improving the quality of life and the life expectancy of the 200,000 Americans with this syndrome.”
Thus, our client’s education, experience, expertise, record of publication and citation, and history of successful research in the field all indicate that she is well-positioned to advance the proposed endeavor. We are pleased that our efforts and hard work, in this case, paid off well in proving that our client’s major contributions in her field of expertise make her an invaluable asset to the United States, thus, she received her NIW (National Interest Waiver) approval even after waiting for long. Therefore, we thank her for choosing the North America Immigration Law Group to represent her case and wish he very well as she continues to advance in her proposed field.